Navigation Links
Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
Date:12/12/2007

diesse for many of their patients is first and foremost that they believe their patients are more satisfied with Radiesse than other dermal filler options. The published report of the comparative study of Radiesse against leading hyaluronic acid fillers demonstrates this difference in a well-controlled clinical study setting," commented Steven Basta, Chief Executive Officer of BioForm Medical. "We are grateful to the many investigators in the U.S. and European clinical studies, and to the leading physicians who routinely take time out of their practice to report on their growing positive experiences with Radiesse."

Radiesse vs. Juvederm and Perlane Clinical Trial

A 205-patient comparative study was conducted at five clinical sites in Europe to assess patient satisfaction and aesthetic improvement in treating nasolabial folds with Radiesse dermal filler as compared to three leading hyaluronic acid fillers, Perlane and two forms of Juvederm. The results of this prospective, multi-center, randomized study, led by Marion Moers-Carpi, MD, Hautok, Munich, Germany, demonstrated higher patient satisfaction, higher likelihood to return for additional treatment, and a greater likelihood to recommend treatment with Radiesse dermal filler, as compared to the three hyaluronic acid products tested: Juvederm 24 (not available in the U.S.), Juvederm 24HV (known as Juvederm Ultra in the U.S.) and Perlane. The study was designed to measure the results achieved by several products on a comparative basis after the completion of two treatments, at baseline and at four months in order to achieve optimal correction. The paper published in the Journal of Dermatologic Surgery reports on results achieved through a 12-month follow-up after the second treatment.

The results from the study demonstrated that at 12 months after the last injection, 90% of Radiesse treated patients rated their satisfaction as "satisfied" or "extremely satisfied" compared to 48% with Perlane (p<
'/>"/>

SOURCE BioForm Medical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
2. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
3. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
4. Raptor Pharmaceuticals Provides Update of Product Programs
5. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
6. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
7. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
8. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
9. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
10. Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin
11. Improved Cornea Surgery Technique Provides Enhanced Transplant Success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 ... addition of the "Investigation Report on China,s ... offering. Developed by Novo Nordisk, insulin ... an important drug for the treatment of diabetes. ... fast- acting insulin analog, starts working fast and ...
(Date:8/28/2015)... , Aug. 28, 2015  IP Shakti, LLC, today announced ... Logo - ... "Our new corporate identity signifies our transformation into a ... predictive analytics platform for patent claim validity." ... of the proprietary AIA Shield™ platform, the Company commenced a ...
(Date:8/28/2015)... and PITTSBURGH , ... MYL ) today announced that its shareholders have ... (NYSE: PRGO ; TASE) and the related ... at an extraordinary general meeting of shareholders held ... votes cast at the extraordinary general meeting. In ...
Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9
... THOUSAND OAKS, Calif., Sept. 14 Amgen (Nasdaq: ... Bank of America Merrill Lynch Global Healthcare Conference ... at 9:50 a.m. Greenwich Mean Time.  Amgen executives ... Willard Dere, M.D., senior vice president, International Chief ...
... Sept. 14 Praxis EMR has submitted its application to ... apply for HITECH certification in the country. Under the ARRA ... incentives if they can demonstrate "meaningful use" of a certified ... Department of Health and Human Services to test and certify ...
Cached Medicine Technology:Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference 2Praxis EMR Among First to Apply for HITECH Certification 2
(Date:8/29/2015)... Aliso Viejo, CA (PRWEB) , ... August 29, 2015 , ... ... Cut Pro X . Each preset contains 15 seconds of unique footage that users ... presets that rise, fall, zoom, attract and more. Users can customize color, brightness, scale, ...
(Date:8/28/2015)... , ... August 29, 2015 , ... Rio Salado ... learning and the student experience as part of the EDUCAUSE - Next Generation Learning ... . , This is the third Breakthrough Models Incubator hosted by EDUCAUSE ...
(Date:8/28/2015)... ... August 28, 2015 , ... An article published ... maker Paul LaRocco has gone through to open a pizzeria in Westchester. Mr. LaRocco ... tends to take several months, but the current process, having already gone on for ...
(Date:8/28/2015)... ... , ... The 6th Annual Survivor in the City, Chicago silent auction ... accolade to its cadre of widespread support—an official letter of support and gratitude from ... medical community and the University of Illinois at Chicago’s Department of Neurosurgery, the Brain ...
(Date:8/28/2015)... Chicago,IL (PRWEB) , ... August 28, 2015 , ... ... Stencils Device Library for documenting and diagramming network and data center assets and ... Manufacturer / Device Model, Cisco Nexus 5000 Series, HP ProLiant Gen9, EMC VNX ...
Breaking Medicine News(10 mins):Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3
... the verbal IQ levels of children exposed to the epilepsy drug ... to the drug.// ,The study was conducted in 249 children ... mothers with epilepsy and tests were performed on both the mother ... ,It was seen that 41 children exposed to valproic acid during ...
... condition, often present at birth. It is marked by a ... extreme cases, it can make the hip prone to dislocation.// ... strong independent indicator for the development of osteoarthritis (OA) of ... of the leading causes of disability among the elderly. In ...
... a recent study researchers focused on the use ... their impact on cholesterol and C-reactive protein levels. ... the liver that predicts inflammation in the arteries. ... important key to determining cardiovascular risk.,Researchers focused on ...
... worldwide. Problems with a patient's urethra causes urine ... heavy objects. Austrian researchers say // they are ... cells, which they say makes the treatment especially ... from a patient's arm, culture them for six ...
... disorder caused by abnormal surges in the electrical circuits of ... affect more than 2 million people worldwide. More than half ... medications. // ,Researchers now say that a new study ... compared to drug therapy when treating those with temporal lobe ...
... nearly 30 years worth of data on breast cancer patients ... stages of disease at diagnosis and those who are diagnosed ... the most likely to die from the disease. Black women ... white women, as are those whose tumors are negative for ...
Cached Medicine News:
... Testosterone, (17-Hydroxy-4-androstene-3-one), a C19 steroid, is one ... [1]. In postpubertal males, testosterone is secreted ... small amount derived from peripheral conversion of ... been estimated that over 50% of serum ...
... Thyroid-stimulating hormone (TSH) is a 32 kDa ... the anterior pituitary gland [1]. The structure ... of the pituitary and placental gonadotropins, consisting ... identical between these hormones and a unique ...
... Thyroxine (T4) is the primary active ... the thyroid gland [1]. T4 is synthesized ... iodide trapping by the follicular cells, (ii) ... substrate leading to formation of 3-monoiodotyrosine and ...
... primarily by 5-monodeioination of thyroxine (T4) in ... production occurs at a rate which is ... of T3 from the thyroid gland into ... to 80-100 micrograms/day for T4. In addition, ...
Medicine Products: